Difference between revisions of "Category:Myeloproliferative neoplasms"
Jump to navigation
Jump to search
m |
(→NCCN) |
||
| Line 4: | Line 4: | ||
===Older=== | ===Older=== | ||
*'''2016:''' Mesa et al. [https://doi.org/10.6004/jnccn.2016.0169 Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology] [https://pubmed.ncbi.nlm.nih.gov/27956542/ PubMed] | *'''2016:''' Mesa et al. [https://doi.org/10.6004/jnccn.2016.0169 Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology] [https://pubmed.ncbi.nlm.nih.gov/27956542/ PubMed] | ||
| + | |||
[[Category:Malignant hematologic neoplasm]] | [[Category:Malignant hematologic neoplasm]] | ||
=Diagnostic criteria= | =Diagnostic criteria= | ||
*'''2022:''' Arber et al. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479031/ International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data] | *'''2022:''' Arber et al. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479031/ International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data] | ||
Revision as of 17:04, 30 November 2023
Guidelines
NCCN
Older
- 2016: Mesa et al. Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology PubMed
Diagnostic criteria
Pages in category "Myeloproliferative neoplasms"
The following 15 pages are in this category, out of 15 total.